Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors

Abstract The current scientific literature has extensively explored the potential role of proteasome inhibitors (PIs) in the NF-κB pathway of leukemia and lymphoma. The ubiquitin-proteasome system (UPS) is a critical component in regulating protein degradation in eukaryotic cells. PIs, such as BTZ,...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, Niloofar Jaafari, Reyhane Khademi, Ali Amini, Majid Safa
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-02-01
Serija:	Cell Communication and Signaling
Teme:	Proteasome Proteasome inhibitors NF-κB, leukemia Lymphoma
Online dostop:	https://doi.org/10.1186/s12964-023-01433-5
Oznake:	Označite Brez oznak, prvi označite!